• Yasutaka Koga, Motoki Fujita, Takeshi Yagi, Masaki Todani, Takashi Nakahara, Yoshikatsu Kawamura, Kotaro Kaneda, Yasutaka Oda, and Ryosuke Tsuruta.
• Advanced Medical Emergency and Critical Care Center, Yamaguchi University Hospital, Ube, Yamaguchi, Japan. Electronic address: koga-ygc@umin.ac.jp.
• J Crit Care. 2018 Oct 1; 47: 153-158.

PurposeTo determine whether the association of early enteral nutrition (EEN) with mortality from sepsis differs between patients with and without sarcopenia.Materials And MethodsWe retrospectively reviewed septic patients treated at our centre between January 2010 and August 2017. The skeletal muscle area (SMA) at the level of the third lumbar vertebra was measured with CT on admission, and sarcopenia was defined as SMA < 80% of the predicted value. Patients were divided into two subgroups (sarcopenic and non-sarcopenic patients), and in-hospital mortality was compared in patients treated with and without EEN within each subgroup. We used logistic regression to examine factors associated with in-hospital mortality in each subgroup.ResultsEEN was administered to 35/91 sarcopenic patients and 43/100 non-sarcopenic patients. In-hospital mortality did not differ between non-sarcopenic patients with EEN and those without EEN (16% vs 16%, P = 0.947), but was significantly lower in sarcopenic patients with EEN than in those without EEN (9% vs 34%, P = 0.005). Logistic regression showed that EEN was independently associated with reduced in-hospital mortality in sarcopenic patients (OR 0.18, 95% CI 0.05-0.71, P = 0.014), but not in non-sarcopenic patients.ConclusionsEEN may be more beneficial in sarcopenic patients.Copyright © 2018 Elsevier Inc. All rights reserved.

24 keywords...

hide…